Onset and duration of action of sildenafil for the treatment of erectile dysfunction
- 1 February 2002
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 53 (s1) , 61S-65S
- https://doi.org/10.1046/j.0306-5251.2001.00034.x
Abstract
Aims To determine the onset and duration of action of sildenafil in patients with erectile dysfunction (ED). Methods Two randomised, double-blind, placebo-controlled, two-way crossover studies were conducted in men with ED of no known organic cause. Study I: The time to onset of erections after sildenafil (50 mg) or placebo dosing following visual sexual stimulation (VSS) was assessed in 17 patients. Patients not achieving >60% penile rigidity by 70 min postdose as measured by a RigiScan® monitoring device were assigned an onset time of 70 min. Study II: The duration of grade 3 (hard enough for penetration) and grade 4 (fully hard) erections, determined by self-assessment during 60 min of VSS starting 2 and 4 h after sildenafil (100 mg) or placebo dosing, was measured in 16 patients. Results Study I: The median time (range) to onset of erections was 27 min (in a range of 12–70) after receiving sildenafil 50 mg. In the sildenafil group, 71% of patients experienced onset of erections within 30 min of dosing, and 82% responded within 45 min. Of the patients who achieved >60% penile rigidity after sildenafil, 86% had done so by 30 min after dosing. Study II: When VSS began 2 h postdose, the median duration of grade 3 or 4 erections was 19.5 min (0–55) for sildenafil vs 0 min (0–23) for placebo. When VSS began 4 h postdose, the median duration was 5 min (0–45) for sildenafil compared with 0 min for placebo (0–27). Conclusions Sildenafil is an effective oral treatment for ED that produces a penetrative erection as early as 12 min and for most patients, within 30 min after dosing, and a duration of action lasting at least 4 h.Keywords
This publication has 17 references indexed in Scilit:
- Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologiesUrology, 1999
- Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart diseaseThe American Journal of Cardiology, 1999
- Overall cardiovascular profile of sildenafil citrateThe American Journal of Cardiology, 1999
- Sildenafil for Treatment of Erectile Dysfunction in Men With DiabetesJAMA, 1999
- Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group.1998
- NOCTURNAL PENILE TUMESCENCE AND RIGIDITY MONITORING IN YOUNG POTENT VOLUNTEERS: REPRODUCIBILITY, EVALUATION CRITERIA AND THE EFFECT OF SEXUAL INTERCOURSEJournal of Urology, 1998
- Clinical safety of oral sildenafil citrate (VIAGRATM) in the treatment of erectile dysfunctionInternational Journal Of Impotence Research, 1998
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- Evaluation of Real-Time Rigiscan Monitoring in Pharmacological ErectionJournal of Urology, 1995
- Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic NeurotransmissionNew England Journal of Medicine, 1992